ARTL CIK: 1621221

Artelo Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.42
FY22:
−10.3
FY23:
−9.93
FY24:
−10.1
FY25:
−11.4
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−10.3
FY23:
−9.93
FY24:
−10.4
FY25:
−11.4
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−10.1
FY23:
−9.29
FY24:
−9.83
FY25:
−12.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.41
FY22:
−10.1
FY23:
−9.29
FY24:
−9.83
FY25:
−12.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data